Company intelligence
CVRx | Barostim
CVRx’s Barostim is a breakthrough technology that stimulates the body’s natural baroreflex to treat heart failure
About CVRx | Barostim
CVRx is a commercial stage, public (NASDAQ: CVRX) medical devices company located in Minneapolis, Minnesota. The company has developed proprietary implantable technology for the treatment of high blood pressure and heart failure. Barostim™ triggers carotid baroreceptors - the body’s own natural blood flow regulation system - which signals the brain to regulate cardiovascular function. Patient Stories on CVRx: The accounts and quotes of patients are genuine and documented. These stories represent a unique individual experience and does not provide any indication, guide, warranty or guarantee as to the response other people may have to CVRx technologies. Barostim is a prescriptive device. For a list of all potential benefits and risks go to www.cvrx.com/benefit-risk-analysis/
Verified activity
Signals from CVRx | Barostim
3 published signals
Products & Services
CVRx | Barostim announced that the team at Harzklinikum Dorothea Christiane Erxleben successfully completed their first Barostim implant.
Reported by CVRx | Barostim
Presence & Recognition
CVRx | Barostim is attending the HFSA2026 conference on October 11, 2026, at the Exhibit Hall, Theater 2, featuring discussions on building and sustaining a successful Barostim program.
Reported by CVRx | Barostim
Partnerships
CVRx | Barostim partnered with Dr. Gilbert Postler, Dr. Michol Cooper, and the team at Florida Medical Clinic Orlando Health on their first Barostim implant.
Reported by CVRx | Barostim